Analyst Coverage That Needs Your Attention: MEI Pharma, Inc. (NASDAQ:MEIP), Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV)

MEI Pharma, Inc. (NASDAQ:MEIP) showed a growth of 5.43% from the market’s prior closing price. That gain sent the price at $2.91 per share as of July 11,2017 when the total trading capacity was higher compared with their three months average volume of 387.68TH shares. The consensus analyst PT for this stock has now been moved to $3.58.

MEI Pharma, Inc. (MEIP) Price Indications

The firm keeps price-to-earnings ratio at 181.88 in 12 months. In last trade, the intraday high was $2.94, putting the share price -10.74% below its 52-week high and trades 120.45% higher from the lowest price they have traded at during the previous year. It turned higher 46.72% from its 50-day simple moving average. The current price is up 72.20% from the average market prices over a 200-day period.

MEI Pharma, Inc. (NASDAQ:MEIP) Thorough Brokerage Views

There are numerous brokerage names which are spending time researching on this stock. Of them, 0 have a Sell, 1 suggested Buy, 1 said Outperform and 2 called Hold rating for the stock, based on Thomson Reuters I/B/E/S. 0 recommends the stock is “underperforming”. The company has a Consensus Recommendation of 2.25, according to Thomson Reuters data.

On July 11,2017, Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) closed session down at $1.29 with -33.85%. The institutional holdings in the company makes up – while the Beta factor is -. The stock’s RSI (Relative Strength Index) reached 38.62.

Kitov Pharmaceuticals Holdings Ltd. (KTOV) Price Potential

In recent trade, the price was -50.10% down its 200 day moving average and was brought -27.33% down versus its 50-day simple moving average. The stock exchanged hands at a volume of 1.79M shares whereas, the average volume was 118.99K shares. In the past 12 months, the share price floated in the $1.38 -$4.55 range. The market capitalization arrived at market cap 195.71M billion. After the day trading kicked off at $1.32, the stock was seen approaching $1.27 as its bottom price and $1.35 as its intraday high price. In previous session, the price was settled at $1.95.

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ:KTOV) Analyst Point of Interest

There were more than a few analysts who recently mentioned the stock in their research. Currently the stock is holding a ‘Buy’ rating from equity analysts. Wall Street brokerages assign ‘Sell’ rating for the firm. 1 analysts are of a belief the stock is a ‘Hold’. ‘Underperform’ verdict was provided by 1 analysts and ‘Overweight’ verdict was shared by 1 analysts. The company has a Mean Recommendation of 1 based on a scale of 1-5 provided by Thomson Reuters.

Previous ArticleNext Article

Related Post

How Insiders and Institutions are Trading WPX Ener... Recent insider trends for WPX Energy, Inc. (NYSE:WPX) have caught the attention of investors. Analysts monitor insider data to understand the sentimen...
Analyzing the Insider Data for Ambev S.A. (ABEV) Recent insider trends for Ambev S.A. (NYSE:ABEV) have caught the attention of investors. Patters in insider activity can help analysts formulate an ou...
What the Insider Data Suggests About Cenveo, Inc. ... Recent insider trends for Cenveo, Inc. (NASDAQ:CVO) have caught the attention of investors. Analysts study insider data to get a sense of sense of wha...
Facebook, Inc. (FB) Forming A Pattern Of Major Mov... Facebook, Inc. (NASDAQ:FB) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 498.03B, th...
Are Investors Buying or Selling Real Goods Solar, ... Recent insider trends for Real Goods Solar, Inc. (NASDAQ:RGSE) have caught the attention of investors. Insider activity is often a strong indicator of...

Leave a Reply

Your email address will not be published.